Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Highlights into historical and current immune interventions for cancer

International Immunopharmacology(2023)10.1016/j.intimp.2023.109882Source: DataRank Database

Highlights into historical and current immune interventions for cancer is a research paper published in International Immunopharmacology (2023). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.73)OA: greenTopics (33)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Zaid Al‐Kadhimi ORCID,James E. Talmadge ORCID,Kathryn Cole ORCID

Live enrichment

PubMed:36848790 PMC:PMC10355273 OpenAlex:https://openalex.org/W4322491068

National Institutes of Health

Grant: P30 CA036727

National Institutes of Health

Grant: P50 CA127297

NCI NIH HHS

Grant: U01 CA210240

Fred and Pamela Buffett Cancer Center

FWCI

1.73

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10355273/pdf/nihms-1879718.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1567576923002023?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1567576923002023?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10355273

Fields of Study

Cancer Immunotherapy and BiomarkersCAR-T cell therapy researchImmune Cell Function and InteractionHumansFemaleBCG VaccineUterine Cervical NeoplasmsPapillomavirus InfectionsImmunotherapyUrinary Bladder NeoplasmsMycobacterium bovis

MeSH Terms

BCG VaccineUrinary Bladder NeoplasmsUterine Cervical NeoplasmsFemaleHumansImmunotherapyMycobacterium bovisPapillomavirus Infections

Keywords

ImmunotherapyMedicineCancerCancer immunotherapyImmunologyImmune systemChimeric antigen receptorOncologyInternal medicineVaccineCheckpoint InhibitorsBacille Calmette-guérinCar-tAnd Adjuvant

Sustainable Development Goals

SDG 0: Good health and well-being

Highlights into historical and current immune interventions for cancer

FAIR Checklist

Authors (3)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)